Non-alcoholic fatty liver disease is associated with progression of arterial stiffness

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 2, 2015, Pages 218-223

  Li, N ^a   Zhang, G w ^a   Zhang, J r ^a   Jin, D ^a   Li, Y ^a   Liu, T ^b   Wang, R t ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arterial stiffness; Brachial ankle pulse wave velocity; Non alcoholic fatty liver disease

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTERIAL STIFFNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BRACHIAL ANKLE PULSE WAVE VELOCITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ECHOGRAPHY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ANKLE BRACHIAL INDEX; BLOOD FLOW VELOCITY; BODY MASS; CARDIOVASCULAR DISEASE; COMPLICATION; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PULSATILE FLOW; PULSE WAVE;

ANKLE BRACHIAL INDEX; BLOOD FLOW VELOCITY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROSPECTIVE STUDIES; PULSATILE FLOW; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84922069983     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.10.002     Document Type: Article

References (29)

1. Bhatia L.S., Curzen N.P., Byrne C.D. Nonalcoholic fatty liver disease and vascular risk. Curr Opin Cardiol 2012, 27:420-428.
2. Lazo M., Hernaez R., Bonekamp S., Kamel I.R., Brancati F.L., Guallar E., et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011, 343:d6891.
3. Soderberg C., Stal P., Askling J., Glaumann H., Lindberg G., Marmur J., et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010, 51:595-602.
4. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002, 25:359-364.
5. Satoh H., Kishi R., Tsutsui H. Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japanese subjects. Hypertens Res 2009, 32:1067-1071.
6. Tomiyama H., Tanaka H., Hashimoto H., Matsumoto C., Odaira M., Yamada J., et al. Arterial stiffness and declines in individuals with normal renal function/early chronic kidney disease. Atherosclerosis 2010, 212:345-350.
7. Turin T.C., Kita Y., Rumana N., Takashima N., Kadota A., Matsui K., et al. Brachial-ankle pulse wave velocity predicts all-cause mortality in the general population: findings from the Takashima study. Jpn Hypertens Res 2010, 33:922-925.
8. Xu L., Jiang C.Q., Lam T.H., Yue X.J., Cheng K.K., Liu B., et al. Brachial-ankle pulse wave velocity and cardiovascular risk factors in the non-diabetic and newly diagnosed diabetic Chinese: Guangzhou Biobank Cohort Study-CVD. Diabetes Metab Res Rev 2010, 26:133-139.
9. Huang Y., Bi Y., Xu M., Ma Z., Xu Y., Wang T., et al. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler Thromb Vasc Biol 2012, 32:2321-2326.
10. Kim B.J., Kim N.H., Kim B.S., Kang J.H. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. Cardiology 2012, 123:54-61.
11. Salvi P., Ruffini R., Agnoletti D., Magnani E., Pagliarani G., Comandini G., et al. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J Hypertens 2010, 28:1699-1707.
12. Harris T.J., Owen C.G., Victor C.R., Adams R., Ekelund U., Cook D.G. A comparison of questionnaire, accelerometer, and pedometer: measures in older people. Med Sci Sports Exerc 2009, 41:1392-1402.
13. Adams L.A., Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet Med 2005, 22:1129-1133.
14. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163.
15. Wang R.T., Li Y., Zhu X.Y., Zhang Y.N. Increased mean platelet volume is associated with arterial stiffness. Platelets 2011, 22:447-451.
16. Li R.Y., Cao Z.G., Zhang J.R., Li Y., Wang R.T. Decreased serum bilirubin is associated with silent cerebral infarction. Arterioscler Thromb Vasc Biol 2014, 34:946-951.
17. Targher G., Bertolini L., Padovani R., Rodella S., Zoppini G., Zenari L., et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006, 29:1325-1330.
18. Villanova N., Moscatiello S., Ramilli S., Bugianesi E., Magalotti D., Vanni E., et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005, 42:473-480.
19. Wong V.W., Wong G.L., Yip G.W., Lo A.O., Limquiaco J., Chu W.C., et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011, 60:1721-1727.
20. Bhatia L.S., Curzen N.P., Calder P.C., Byrne C.D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor. Eur Heart J 2012, 33:1190-1200.
21. Mahmud A., Feely J. Adiponectin and arterial stiffness. Am J Hypertens 2005, 18:1543-1548.
22. Yoneda M., Mawatari H., Fujita K., Iida H., Yonemitsu K., Kato S., et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007, 42:573-582.
23. Gastaldelli A., Basta G. Ectopic fat and cardiovascular disease: what is the link. Nutr Metab Cardiovasc Dis 2010, 20:481-490.
24. Lai Y.H., Yun C.H., Yang F.S., Liu C.C., Wu Y.J., Kuo J.Y., et al. Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography. J Am Soc Echocardiogr 2012, 25:234-241.
25. Xu Y., Cheng X., Hong K., Huang C., Wan L. How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron Artery Dis 2012, 23:227-233.
26. Safar M.E., Thomas F., Blacher J., Nzietchueng R., Bureau J.M., Pannier B., et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006, 47:72-75.
27. Cho E.R., Shin A., Kim J., Jee S.H., Sung J. Leisure-time physical activity is associated with a reduced risk for metabolic syndrome. Ann Epidemiol 2009, 19:784-792.
28. Rodriguez B., Torres D.M., Harrison S.A. Physical activity: an essential component of lifestyle modification in NAFLD. Nat Rev Gastroenterol Hepatol 2012, 9:726-731.
29. Strasser B. Physical activity in obesity and metabolic syndrome. Ann N Y Acad Sci 2013, 1281:141-159.